Effect of tolvaptan on the prognosis of patients with hepatic ascites-Reference-Cited by-同舟云学术

Effect of tolvaptan on the prognosis of patients with hepatic ascites

Published:2019-04-30 Issue:7 Volume:49 Page:765-777
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Hiramine Yasunari¹,Uto Hirofumi²³,Mawatari Seiichi³^ORCID,Kanmura Shuji³,Imamura Yasushi¹,Hiwaki Takuya¹,Saishoji Akiko¹³,Yada Takazumi²,Inada Yukiko²,Sakamoto Hidemori²,Higashi Hirofumi⁴,Kubozono Osamu¹,Maenohara Shigeho⁵,Ido Akio³

Affiliation:

1. Department of Internal Medicine Kagoshima Kouseiren Hospital Kagoshima Japan

2. Center for Digestive and Liver Diseases Miyazaki Medical Center Hospital Miyazaki Japan

3. Digestive and Lifestyle Diseases, Department of Human and Environmental Sciences Kagoshima University Graduate School of Medical and Dental Sciences Kagoshima Japan

4. Department of Hygiene and Public Health National Institute of Fitness and Sports in Kanoya Kagoshima Japan

5. Department of Surgery Kagoshima Kouseiren Hospital Kagoshima Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13337

Reference46 articles.

1. Natural History of Patients Hospitalized for Management of Cirrhotic Ascites

2. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

3. Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia